既存薬の作用分子機構の解明と創薬への展開
スポンサーリンク
概要
- 論文の詳細を見る
As a new strategy for drug discovery and development, we propose here the establishment of drug re-profiling strategy. In this strategy, the actions of existing medicines, whose safety and pharmacokinetic effects in humans have been confirmed already, are examined comprehensively at the molecular level and the results are used for the development of new medicines. For example, identification of the mechanisms underlying the side effects of medicines enables us to develop safer drugs. The results can also be used for developing existing drugs for use as medicines in treatment of other diseases. Promoting this research strategy could provide breakthroughs in drug discovery and development by pharmaceutical companies.
- 公益社団法人 日本薬学会の論文
著者
関連論文
- 非ステロイド系抗炎症薬の新しい薬理効果とその分子機構
- 胃潰瘍を起こしにくいロキソプロフェン誘導体, フルオロロキソプロフェンに関する研究
- 胃潰瘍治癒に対するHSP70の促進効果
- 既存薬の作用分子機構の解明と創薬への展開
- 胃潰瘍を起こしにくいロキソプロフェン誘導体, フルオロロキソプロフェンに関する研究